The improvement of cognitive functions in patients with bronchial asthma after therapy.
Bozek
Andrzej
A
Clinical Department of Internal Medicine, Dermatology and Allergology, Silesian University School of Medicine, Zabrze, Poland. andrzejbozek@o2.pl
Krajewska
Jolanta
J
Jarzab
Jerzy
J
D000368:Aged; D000369:Aged, 80 and over; D000420:Albuterol / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000150:complications* / Q000188:drug therapy*; D019819:Budesonide / Q000008:administration & dosage*; D003072:Cognition Disorders / Q000150:complications* / Q000175:diagnosis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D000068299:Salmeterol Xinafoate; D013147:Spirometry
D018927:Anti-Asthmatic Agents; D019819:Budesonide; D000068299:Salmeterol Xinafoate; D000420:Albuterol